Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers: Results from the FAST study von Schuler, Martin H., Al-Batran, Salah-Eddin, Zvirbule, Zanete, Manikhas, Georgy, Lordick, Florian, Rusyn, Andriy V., Vynnychenko, Ihor, Dudov, Assen, Bazin, Igor, Melichar, Bohuslav, Dhaene, Karl, Wiechen, Kai, Maurus, Daniel, Tureci, Özlem, Sahin, Ugur

Volltext

Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive... von Stebbing, Justin, Baranau, Yauheni Valerievich, Baryash, Valery, Manikhas, Alexey, Moiseyenko, Vladimir, Dzagnidze, Giorgi, Javrid, Edvard, Boliukh, Dmytro, Stroyakovskiy, Daniil, Pikiel, Joanna, Eniu, Alexandru E., Komov, Dmitry, Zautashvili, Zakaria, Morar-Bolba, Gabriela, Li, Rubi Khaw, Lifirenko, Igor, Rusyn, Andriy V., Lee, Sang Joon, Lee, Sung Young, Esteva, Francisco J.

Volltext